Company / Interest Expense
Immunocore Holdings plc Interest Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$12.2M
FY2025
5-year range
$5.2M / $18.8M
FY2021-FY2025
Trend
-35.4%
vs FY2024
Sector context
#24 of 44
Health Care
What the data says
At $12M, Immunocore Holdings plc's interest expense ranks #21 of 44 in the Health Care sector. Increased from $5M to $12M over the past 2 years.
Based on SEC 10-K filings.
$12M in FY2025 with a 3-year CAGR of +31.0%.
Increased from $5M to $12M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +31.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#21 of 44 in Health CareTop 45% of 44This company $12.2M Sector average $291.0M
▼
-95.8% below sector average
Key checks
Key Insights
- 3-year CAGR of +31.0%, indicating consistent growth.
- In FY2025, interest expense decreased 35.4% year-over-year.
- Ranks #24 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.2M | -35.4% |
| FY2024 | $18.8M | +265.6% |
| FY2023 | $5.2M | -4.7% |
| FY2022 | $5.4M | -2.9% |
| FY2021 | $5.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026